Home › Therapeutic areas › Respiratory › Asthma
Asthma (7 companies)
Companies with an active program in Asthma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics | DermatologyGI/Hepatology+1 Rare | 1 | Phase 2 | $619M | 8 |
| APGE | Apogee Therapeutics | DermatologyGI/Hepatology+1 Rare | 3 | Phase 2 | — | 9 |
| CLDX | Celldex Therapeutics | DermatologyImmunology+1 | 1 | Phase 3 | $2.35B | 9 |
| CNTB | Connect Biopharma | Respiratory | 2 | Phase 2 | $45.9M | 4 |
| CRVS | Corvus Pharmaceuticals | DermatologyOncology+1 Rare | 1 | Phase 3 | $889M | 7 |
| INSM | Insmed | CardiovascularImmunology+3 Rare | 1 | Approved | $25.1B | 15 |
| KYMR | Kymera Therapeutics | DermatologyImmunology+1 Rare | 1 | Phase 2 | $11.2B | 5 |
No companies match.